SEARCH

SEARCH BY CITATION

References

  • 1
    Vincenti F. A decade of progress in kidney transplantation. Transplantation 2004; 77 (9 Suppl.): S52S61.
  • 2
    Busuttil RW, Lake JR. Role of tacrolimus in the evolution of liver transplantation. Transplantation 2004; 77 (9 Suppl.): S44S51.
  • 3
    Vincenti F. What's in the pipeline? New immunosuppressive drugs in transplantation. Am J Transplant 2002; 2: 898903.
  • 4
    Tao XL, Dong Y, Zhang NZ. A double-blind study of T2 (tablets of polyglycosides of Tripterygium wilfodii hook) in the treatment of rheumatoid arthritis. Zhonghua Nei Ke Za Zhi 1987; 26: 399402, 444–445.
  • 5
    Yu DY. Clinical observation of 144 cases of rheumatoid arthritis treated with glycoside of Radix Tripterygium Wilfordii. J Tradit Chin Med 1983; 3: 125129.
  • 6
    Qin WZ, Yang SM. Tripterygium wilfordii Hook F in systemic lupus erythematosus. Chin Med J 1981; 94: 827828.
  • 7
    Chen Y, Zeng D, Schlegel PG, Fidler J, Chao NJ. PG27, an extract of Tripterygium wilfordii hook f, induces antigen-specific tolerance in bone marrow transplantation in mice. Blood 2000; 95: 705710.
  • 8
    Wang J, Xu R, Jin R, Chen Z, Fidler JM. Immunosuppressive activity of the Chinese medicinal plant Tripterygium wilfordii. I. Prolongation of rat cardiac and renal allograft survival by the PG27 extract and immunosuppressive synergy in combination therapy with cyclosporine. Transplantation 2000; 70: 447455.
  • 9
    Fidler JM, Ku GY, Piazza D, Xu R, Jin R, Chen Z. Immunosuppressive activity of the Chinese medicinal plant Tripterygium wilfordii. III. Suppression of graft-versus-host disease in murine allogeneic bone marrow transplantation by the PG27 extract. Transplantation 2002; 74: 445457.
  • 10
    Kupchan SM, Court WA, Dailey RG Jr., Gilmore CJ, Bryan RF. Triptolide and tripdiolide, novel antileukemic diterpenoid triepoxides from Tripterygium wilfordii. J Am Chem Soc 1972; 94: 71947195.
  • 11
    Qiu D, Zhao G, Aoki Y et al. Immunosuppressant PG490 (triptolide) inhibits T-cell interleukin-2 expression at the level of purine-box/nuclear factor of activated T-cells and NF-kappaB transcriptional activation. J Biol Chem 1999; 274: 1344313450.
  • 12
    Lee KY, Chang W, Qiu D, Kao PN, Rosen GD. PG490 (triptolide) cooperates with tumor necrosis factor-alpha to induce apoptosis in tumor cells. J Biol Chem 1999; 274: 1345113455.
  • 13
    Chan MA, Kohlmeier JE, Branden M, Jung M, Benedict SH. Triptolide is more effective in preventing T cell proliferation and interferon-gamma production than is FK506. Phytother Res 1999; 13: 464467.
  • 14
    Chen BJ, Liu C, Cui X, Fidler JM, Chao NJ. Prevention of graft-versus-host disease by a novel immunosuppressant, PG490-88, through inhibition of alloreactive T cell expansion. Transplantation 2000; 70: 14421447.
  • 15
    Wang X, Sun H, Chen G et al. Immunosuppression with a combination of PG490-88 and a subtherapeutic dose of FK506 in a canine renal allograft model. Transplantation 2005; 79: 15371544.
  • 16
    Wang J, Xu R, Jin R, Chen Z, Fidler JM. Immunosuppressive activity of the Chinese medicinal plant Tripterygium wilfordii. II. Prolongation of hamster-to-rat cardiac xenograft survival by combination therapy with the PG27 extract and cyclosporine. Transplantation 2000; 70: 456464.
  • 17
    Knapp LA, Lehmann E, Hennes L, Eberle ME, Watkins DI. High-resolution HLA-DRB typing using denaturing gradient gel electrophoresis and direct sequencing. Tissue Antigens 1997; 50: 170177.
  • 18
    Yang H, Chen G, Kanai N et al. Monotherapy with LF 15-0195, an analogue of 15-deoxyspergualin, significantly prolongs renal allograft survival in monkeys. Transplantation 2003; 75: 11661171.
  • 19
    Brunet M, Pou L, Torra M, Lopez R, Rodamilans M, Corbella J. Comparative analysis of tacrolimus (FK506) in whole blood liver transplant recipients by PRO-TRAC enzyme-linked immunosorbent assay and microparticle enzyme immunoassay IMX methods. Ther Drug Monit 1996; 18: 706709.
  • 20
    Davis ML, Austin C, Messmer BL, Nichols WK, Bonin AP, Bennett MJ. IFCC-standardized pediatric reference intervals for 10 serum proteins using the Beckman Array 360 system. Clin Biochem 1996; 29: 489492.
  • 21
    Chen G, Qian H, Starzl T et al. Acute rejection is associated with antibodies to non-Gal antigens in baboons using Gal-knockout pig kidneys. Nat Med 2005; 11: 12951298.
  • 22
    Solez K, Axelsen RA, Benediktsson H et al. International standardization of criteria for the histologic diagnosis of renal allograft rejection: the Banff working classification of kidney transplant pathology. Kidney Int 1993; 44: 411422.
  • 23
    Hudkins KL, Gilbertson DG, Carling M et al. Exogenous PDGF-D is a potent mesangial cell mitogen and causes a severe mesangial proliferative glomerulopathy. J Am Soc Nephrol 2004; 15: 286298.
  • 24
    Chou T. The median-effect principle and combination index for quantitation of synergism and antagonism. In: Chou TC, Rideout D, eds. Synergism and Antagonisms in Chemotherapy. San Diego : Academic Press 1991; 6164.
  • 25
    Andersson J, Nagy S, Groth CG, Andersson U. Effects of FK506 and cyclosporin A on cytokine production studied in vitro at a single-cell level. Immunology 1992; 75: 136142.
  • 26
    Yamane M, Sano Y, Shimizu N. Significant changes in the alloantibody after lung transplantation in the cyclosporine treated rat model. Transpl Immunol 2004; 12: 143150.
  • 27
    Kasahara M, Kiuchi T, Takakura K et al. Postoperative flow cytometry crossmatch in living donor liver transplantation: clinical significance of humoral immunity in acute rejection. Transplantation 1999; 67: 568575.
  • 28
    Wang H, Hosiawa KA, Garcia B et al. Treatment with a short course of LF 15-0195 and continuous cyclosporin A attenuates acute xenograft rejection in a rat-to-mouse cardiac transplantation model. Xenotransplantation 2003; 10: 325336.
  • 29
    Hong Y, Zhou W, Li K, Sacks SH. Triptolide is a potent suppressant of C3, CD40 and B7h expression in activated human proximal tubular epithelial cells. Kidney Int 2002; 62: 12911300.
  • 30
    Takemoto SK, Zeevi A, Feng S et al. National conference to assess antibody-mediated rejection in solid organ transplantation. Am J Transplant 2004; 4: 10331041.